The first world report of botulinum A toxin injection for status migrainosus.
The author reports the first ever documented publication in the world concerning the use of botulinum toxin A (BTX-A) injection for status migrainosus. A 58-year old man had been suffering from migraine without aura for 20 years. This last attack (a very severe throbbing headache) started over the left side of his head and he had tried several medications (paracetamol, aspirin, ergotamine, mefenamic acid, and diazepam) during the attack to no vail. Physical examination revealed an acutely ill patient with an agonizing pain condition. General and neurological examinations were normal. BTX-A solution was then injected into the Fung Chou point (classical Chinese acupuncture point for migraine) in the total amount of 25 international unit. Dramatic response was observed within 1 hour of injection and status migrainosus was abort within 10 hours. He was headache-free and had no further attack of migraine for another 2 months.
Poungvarin
N
N
Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
D015669:Acupuncture Points; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D010147:Pain Measurement; D013785:Thailand; D013997:Time Factors; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A